Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis

Journal of Clinical Investigation

Volumn 113, Issue 1, 2004, Pages 124-136

  Grundhoff, Adam ^a   Ganem, Don ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIS ACTING ELEMENT; TRANS ACTING FACTOR; GREEN FLUORESCENT PROTEIN; PHOTOPROTEIN;

ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CHROMOSOME; EPIGENETICS; EPISOME; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; TUMOR CELL; VIRUS GENOME; VIRUS REPLICATION; BURKITT LYMPHOMA; CELL CULTURE; GENETICS; KINETICS; PHYSIOLOGY; REPORTER GENE; VIROLOGY; VIRUS LATENCY;

BURKITT LYMPHOMA; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HERPESVIRUS 8, HUMAN; HUMANS; KINETICS; LUMINESCENT PROTEINS; SARCOMA, KAPOSI; TUMOR CELLS, CULTURED; VIRUS LATENCY; VIRUS REPLICATION;

EID: 1542571327     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200417803     Document Type: Article

References (71)

1. Herndier, B., and Ganem, D. 2001. The biology of Kaposi's sarcoma. Cancer Treat. Res. 104:89-126.
2. Delabesse, E., et al. 1997. Molecular analysis of clonality in Kaposi's sarcoma. J. Clin. Pathol. 50:664-668.
3. Gill, P.S., et al. 1998. Evidence for multiclonality in multicentric Kaposi's sarcoma. Proc. Natl. Acad. Sci. U. S. A. 95:8257-8261.
4. Judde, J.G., et al. 2000. Monoclonality or oligoclonality of human herpesvirus 8 terminal repeat sequences in Kaposi's sarcoma and other diseases. J. Natl. Cancer Inst. 92:729-736.
5. Corbeil, J., Evans, L.A., Vasak, E., Cooper, D.A., and Penny, R. 1991. Culture and properties of cells derived from Kaposi sarcoma. J. Immunol. 146:2972-2976.
6. Ensoli, B., et al. 1989. AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science. 243:223-226.
7. Aluigi, M.G., et al. 1996. KSHV sequences in biopsies and cultured spindle cells of epidemic, iatrogenic and Mediterranean forms of Kaposi's sarcoma. Res. Virol. 147:267-275.
8. Lebbe, C., et al. 1997. Characterization of in vitro culture of HIV-negative Kaposi's sarcoma-derived cells. In vitro responses to alfa interferon. Arch. Dermatol. Res. 289:421-428.
9. Salahuddin, S.Z., et al. 1988. Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro. Science. 242:430-433.
10. Herndier, B.G., et al. 1994. Characterization of a human Kaposi's sarcoma cell line that induces angiogenic tumors in animals. AIDS. 8:575-581.
11. Fiorelli, V., Gendelman, R., Samaniego, F., Markham, P.D., and Ensoli, B. 1995. Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells. J. Clin. Invest. 95:1723-1734.
12. Ensoli, B., et al. 1994. Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS. J. Clin. Invest. 94:1736-1746.
13. Ensoli, B., and Sturzl, M. 1998. Kaposi's sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents. Cytokine Growth Factor Rev. 9:63-83.
14. Flamand, L., Zeman, R.A., Bryant, J.L., Lunardi-Iskandar, Y., and Gallo, R.C. 1996. Absence of human herpesvirus 8 DNA sequences in neoplastic Kaposi's sarcoma cell lines. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 13:194-197.
15. Dictor, M., Rambech, E., Way, D., Witte, M., and Bendsoe, N. 1996. Human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) DNA in Kaposi's sarcoma lesions, AIDS Kaposi's sarcoma cell lines, endothelial Kaposi's sarcoma simulators, and the skin of immunosuppressed patients. Am. J. Pathol. 148:2009-2016.
16. Cesarman, E., et al. 1996. Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma. J. Virol. 70:8218-8223.
17. Chang, Y., et al. 1996. Cyclin encoded by KS herpesvirus. Nature. 382:410. (Letter)
18. Li, M., et al. 1997. Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin. J. Virol. 71:1984-1991.
19. Friborg, J., Jr., Kong, W., Hotriger, M.O., and Nabel, G.J. 1999. p53 inhibition by the LANA protein of KSHV protects against cell death. Nature. 402:889-894.
20. Rivas, C., Thlick, A.E., Parravicini, C., Moore, P.S., and Chang, Y. 2001. Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53. J. Virol. 75:429-438.
21. Fujimuro, M., et al. 2003. A novel viral mechanism for dysregulation of beta-catenin in Kaposi's sarcoma-associated herpesvirus latency. Nat. Med. 9:300-306.
22. Orenstein, J.M., et al. 1997. Visualization of human herpesvirus type 8 in Kaposi's sarcoma by light and transmission electron microscopy. AIDS. 11:F35-F45.
23. Staskus, K.A., et al. 1997. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J. Virol. 71:715-719.
24. Martin, D.F., et al. 1999. Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group. N. Engl. J. Med. 340:1063-1070.
25. Benelli, R., et al. 2000. Distinct chemotactic and angiogenic activities of peptides derived from Kaposi's sarcoma virus encoded chemokines. Int. J. Oncol. 17:75-81.
26. Boshoff, C., et al. 1997. Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science. 278:290-294.
27. Haque, N.S., Fallon, J.T., Taubman, M.B., and Harpel, P.C. 2001. The chemokine receptor CCR8 mediates human endothelial cell chemotaxis induced by I-309 and Kaposi sarcoma herpesvirus-encoded vMIP-1 and by lipoprotein(a)-stimulated endothelial cell conditioned medium. Blood. 97:39-45.
28. Liu, C., Okruzhnov, Y., Li, H., and Nicholas, J. 2001. Human herpesvirus 8 (HHV-8)-encoded cytokines induce expression of and autocrine signaling by vascular endothelial growth factor (VEGF) in HHV-8-infected primary-effusion lymphoma cell lines and mediate VEGF-independent antiapoptotic effects. J. Virol. 75:10933-10940.
29. Sozzani, S., et al. 1998. The viral chemokine macrophage inflammatory protein-II is a selective Th2 chemoattractant. Blood. 92:4036-4039.
30. Stine, J.T., et al. 2000. KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells. Blood. 95:1151-1157.
31. Bais, C., et al. 1998. G-protein coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature. 391:86-89.
32. Cesarman, E., Mesri, E.A., and Gershengorn, M.C. 2000. Viral G protein-coupled receptor and Kaposi's sarcoma: a model of paracrine neoplasia? J. Exp. Med. 191:417-422.
33. Kirshner, J.R., Staskus, K., Haase, A., Lagunoff, M., and Ganem, D. 1999. Expression of the open reading frame 74 (G-protein-coupled receptor) gene of Kaposi's sarcoma (KS)-associated herpesvirus: implications for KS pathogenesis. J. Virol. 73:6006-6014.
34. Smit, M.J., et al. 2002. Kaposi's sarcoma-associated herpesvirus-encoded G protein-coupled receptor ORF74 constitutively activates p44/p42 MAPK and Akt via G(i) and phospholipase C-dependent signaling pathways. J. Virol. 76:1744-1752.
35. Yang, T.Y., et al. 2000. Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma. J. Exp. Med. 191:445-454.
36. Grundhoff, A., and Ganem, D. 2003. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus permits replication of terminal repeat-containing plasmids. J. Virol. 77:2779-2783.
37. Lagunoff, M., and Ganem, D. 1997. The structure and coding organization of the genomic termini of Kaposi's sarcoma-associated herpesvirus. Virology. 236:147-154.
38. Renne, R., et al. 2001. Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J. Virol. 75:458-468.
39. Renne, R., et al. 1996. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat. Med. 2:342-346.
40. Venetsanakos, E., et al. 2002. Induction of tubulogenesis in telomerase-immortalized human microvascular endothelial cells by glioblastoma cells. Exp. Cell Res. 273:21-33.
41. Obeso, J., Weber, J., and Auerbach, R. 1990. A hemangioendothelioma-derived cell line: its use as a model for the study of endothelial cell biology. Lab. Invest. 63:259-269.
42. Zhou, F.C., et al. 2002. Efficient infection by a recombinant Kaposi's sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: application for genetic analysis. J. Virol. 76:6185-6196.
43. Gardella, T., Medveczky, P., Sairenji, T., and Mulder, C. 1984. Detection of circular and linear herpesvirus DNA molecules in mammalian cells by gel electrophoresis. J. Virol. 50:248-254.
44. Arad, U. 1998. Modified Hirt procedure for rapid purification of extra-chromosomal DNA from mammalian cells. Biotechniques. 24:760-762.
45. Polson, A.G., et al. 2001. Kaposi's sarcoma-associated herpesvirus K-bZIP protein is phosphorylated by cyclin-dependent kinases. J. Virol. 75:3175-3184.
46. Garber, A.C., Hu, J., and Renne, R. 2002. Latency-associated nuclear antigen (LANA) cooperatively binds to two sites within the terminal repeat, and both sites contribute to the ability of LANA to suppress transcription and to facilitate DNA replication. J. Biol. Chem. 277:27401-27411.
47. Hu, J., Garber, A.C., and Renne, R. 2002. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells. J. Virol. 76:11677-11687.
48. Lim, C., Sohn, H., Lee, D., Gwack, Y., and Choe, J. 2002. Functional dissection of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated herpesvirus involved in latent DNA replication and transcription of terminal repeats of the viral genome. J. Virol. 76:10320-10331.
49. Ballestas, M.E., and Kaye, K.M. 2001. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates episome persistence through cis-acting terminal repeat (TR) sequence and specifically binds TR DNA. J. Virol. 75:3250-3258.
50. Cotter, M.A., II, Subramanian, C., and Robertson, E.S. 2001. The Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen binds to specific sequences at the left end of the viral genome through its carboxy-terminus. Virology. 291:241-259.
51. Garber, A.C., Shu, M.A., Hu, J., and Renne, R. 2001. DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J. Virol. 75:7882-7892.
52. Cotter, M.A., II, and Robertson, E.S. 1999. The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells. Virology. 264:254-264.
53. Piolot, T., Tramier, M., Coppey, M., Nicolas, J.C., and Marechal, V. 2001. Close but distinct regions of human herpesvirus 8 latency-associated nuclear antigen 1 are responsible for nuclear targeting and binding to human mitotic chromosomes. J. Virol. 75:3948-3959.
54. Ballestas, M.E., Chatis, P.A., and Kaye, K.M. 1999. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science. 284:641-644.
55. Bechtel, J.T., Liang, Y., Hvidding, J., and Ganem, D. 2003. Host range of Kaposi's sarcoma-associated herpesvirus in cultured cells. J. Virol. 77:6474-6481.
56. Renne, R., Blackbourn, D., Whitby, D., Levy, J., and Ganem, D. 1998. Limited transmission of Kaposi's sarcoma-associated herpesvirus in cultured cells. J. Virol. 72:5182-5188.
57. Blackbourn, D.J., et al. 2000. The restricted cellular host range of human herpesvirus 8. AIDS. 14:1123-1133.
58. Lagunoff, M., et al. 2002. De novo infection and serial transmission of Kaposi's sarcoma-associated herpesvirus in cultured endothelial cells. J. Virol. 76:2440-2448.
59. Ciufo, D.M., et al. 2001. Spindle cell conversion by Kaposi's sarcoma-associated herpesvirus: formation of colonies and plaques with mixed lytic and latent gene expression in infected primary dermal microvascular endothelial cell cultures. J. Virol. 75:5614-5626.
60. Leight, E.R., and Sugden, B. 2001. Establishment of an oriP replicon is dependent upon an infrequent, epigenetic event. Mol. Cell Biol. 21:4149-4161.
61. Cheung, S.T., et al. 1999. Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus. Int. J. Cancer. 83:121-126.
62. Hui, A.B., Cheung, S.T., Fong, Y., Lo, K.W., and Huang, D.P. 1998. Characterization of a new EBV-associated nasopharyngeal carcinoma cell line. Cancer Genet. Cytogenet. 101:83-88.
63. Babcock, G.J., Decker, L.L., Volk, M., and Thorley-Lawson, D.A. 1998. EBV persistence in memory B cells in vivo. Immunity. 9:395-404.
64. Babcock, G.J., Decker, L.L., Freeman, R.B., and Thorley-Lawson, D.A. 1999. Epstein-Barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients. J. Exp. Med. 190:567-576.
65. Babcock, G.J., Hochberg, D., and Thorley-Lawson, A.D. 2000. The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. Immunity. 13:497-506.
66. Miyashita, E.M., Yang, B., Babcock, G.J., and Thorley-Lawson, D.A. 1997. Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell. J. Virol. 71:4882-4891.
67. Thorley-Lawson, D.A., and Babcock, G.J. 1999. A model for persistent infection with Epstein-Barr virus: the stealth virus of human B cells. Life Sci. 65:1433-1453.
68. Dupin, N., et al. 1999. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc. Natl. Acad. Sci. U. S. A. 96:4546-4551.
69. Boivin, G., Gaudreau, A., and Routy, J.P. 2000. Evaluation of the human herpesvirus 8 DNA load in blood and Kaposi's sarcoma skin lesions from AIDS patients on highly active antiretroviral therapy. AIDS. 14:1907-1910.
70. Campbell, T.B., et al. 2000. Relationship of human herpesvirus 8 peripheral blood virus load and Kaposi's sarcoma clinical stage. AIDS. 14:2109-2116.
71. Quinlivan, E.B., et al. 2002. Elevated virus loads of Kaposi's sarcoma-associated human herpesvirus 8 predict Kaposi's sarcoma disease progression, but elevated levels of human immunodeficiency virus type 1 do not. J. Infect. Dis. 185:1736-1744.